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Abstract
Background The use of antibiotic-coated implants may
reduce the rate of infection and facilitate fracture healing
after surgical treatment of tibial shaft fractures. A new
biodegradable gentamicin-loaded coating of an implant
(UTN PROtect
) was CE-certiﬁed in August 2005. In this
prospective, non-randomized case series, we investigated
the clinical, laboratory and radiological outcomes of 21
patients who underwent surgical treatment in closed or
open tibial fractures, as well as revisions with the UTN
PROtect
 gentamicin-coated intramedullary nail.
Methods Of 21 patients (13 men, 8 women), 19 com-
pleted the 6-month follow-up. The study population
included patients with complex tibial fractures and late
revision cases. Clinical outcomes comprised adverse
events, including infections and the SF-36 physical score.
Laboratory outcomes, including C-reactive protein and
leukocyte count as inﬂammatory markers, haemoglobin
and serum gentamicin, were measured at baseline and up to
6 months post operatively. Radiographic assessments of
fracture healing and weight-bearing capacity were deter-
mined at 5 weeks, 3 and 6 months after surgery.
Results No implant-related infections occurred; one
patient had superﬁcial wound healing problems. Mean
C-reactive protein levels remained below 5 mg/L
throughout the study, with a peak at 4–7 days after surgery
(4.4 mg/L; range 0.5–16.1 mg/L). Leukocyte counts and
haemoglobin levels did not vary over time during the
study. The mean SF-36 physical score at 6 months was
42.6 (range 19.4–56.7). Radiographic union deﬁned as
three or four bridged cortices was achieved in 11 patients
(58%) after 6 months. The remaining eight patients showed
partial fracture healing with one or two bridged cortices.
Additionally, 13 patients (68%) demonstrated full weight-
bearing capacity after 6 months.
Conclusions The use of the UTN PROtect
 intramedul-
lary nail was associated with good clinical, laboratory and
radiological outcomes after 6 months. These preliminary
results support the use of gentamicin-coated implants as a
new potential treatment option for the prevention of
infection in trauma patients and in revision cases.
Level of Evidence Level II.
Keywords Open fracture  Intramedullary nailing  Bone
infection  Antibiotic coating  Osteomyelitis  Tibia  Soft
tissue management
Introduction
Intramedullary nailing is the method of choice for treating
tibial shaft fractures [16]. However, tibial fractures with
severe soft-tissue damage that results in the loss of soft-
tissue support and disrupted vascularity are especially
prone to infection, non-union and other complications [4,
5]. Despite improvements in surgical techniques and the
use of antibiotic therapy, deep wound infections and
osteomyelitis remain serious complications that may lead
to impaired healing, reduced limb function and life-
threatening septic conditions [20, 22].
Rates of infection associated with tibial fractures after
surgical treatment vary depending on the severity of
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7, 15, 16]. Overall infection rates are about 1–4% [2, 5].
Patients with open tibial fractures are at higher risk of
infection, with rates ranging from 6 to 33% [3, 15–17].
Gaebler et al. [5] reported 13 infections (3.2%) among
467 patients after intramedullary tibial nailing, of which 5
(1.1%) were deep wound infections. Notably, 80% of all
deep infections developed in Gustilo grade III open frac-
tures [5]. Other studies have conﬁrmed that the risk of deep
wound infections increases with the severity of soft tissue
injury by Gustilo type and fracture severity by AO type [7,
8, 15, 16].
Systemic prophylactic administration of antibiotics is
accepted as standard practice to control bacterial contam-
ination and prevent infection after surgery. In a review of
seven clinical trials involving 913 patients with open limb
fractures, perioperative administration of systemic antibi-
otics was associated with a 60% reduction in the relative
risk (RR) of early wound infections compared with no
prophylaxis or placebo (RR 0.41; 95% CI 0.27–0.63) [6].
Yet, a systematic review and meta-analysis of 22 trials
involving 927 patients was inconclusive as to which sys-
temic antibiotic provides the best protection against bone
and joint infections [19].
Systemic antibiotics may have limited efﬁcacy in
decreasing the risk of infection associated with the use of
foreign bodies such as prostheses and osteosynthetic
devices [3, 17]. Bacteria can colonize the surface of an
implant, forming a bioﬁlm of an extracellular polysaccha-
ride matrix (glycocalyx) that protects the bacteria from the
antimicrobial action of systemic antibiotics. Furthermore,
systemically delivered antibiotics might not reach the
medullar canal of long bones when blood ﬂow has been
disrupted by trauma or intramedullary nailing [17].
Therefore, implant-related infection often requires aggres-
sive treatment including removal of the implant, multiple
revisions with surgical debridement and long-term antibi-
otic therapy [15, 16, 19].
To improve prophylaxis against implant-related infec-
tions, various systems have been developed for the local
delivery of antibiotics at the tissue-implant interface.
Gentamicin polymethylmethacrylate (PMMA) bead chains
and gentamicin-coated collagen sponges (Sulmycin
;
Septocoll
) can reduce the risk of infection directly at the
site of the implant and its surrounding tissue [3, 9, 17].
However, PMMA beads must be removed after 4–6 weeks
[3] and collagen sponges do not allow for continuous and
controlled release of the antibiotic [4].
Alternatively, a polylactic acid (PLA) coating loaded
with gentamicin offers both sustained release kinetics and
biodegradability [4, 18]. Pre-clinical studies have shown
the effectiveness of gentamicin-coated implants in pre-
venting implant-related ostemyelitis even without systemic
antibiotic prophylaxis [12, 17]. A new tibial titanium nail
with a biodegradable gentamicin-loaded coating (UTN
PROtect
, Synthes) was CE-certiﬁed in August 2005. In a
pilot study of 8 patients with open tibial fractures treated
with UTN PROtect
 intramedullary nails, there were no
infections within 1 year and all fractures healed within
6 months [17].
In this prospective, non-randomized case series, we
investigated the use of the UTN PROtect
 gentamicin-
coated intramedullary tibial nail in the surgical treatment of
closed and open tibial fractures and in revision surgeries.
Here, we report preliminary data on clinical, laboratory and
radiological outcomes in 19 patients who underwent sur-
gical treatment and were followed for 6 months post-
operatively.
The study was conducted at the Universita ¨tsklinikum
Mu ¨nster in accordance with the Declaration of Helsinki.
The protocol was approved by the local institutional review
board (Ethics Committee of the Universita ¨tsklinikum
Mu ¨nster). All patients gave written informed consent.
Patients and methods
UTN PROtect

The UTN PROtect
 implant is a titanium alloy (Ti-6Al-
7Nb) nail used for intramedullary ﬁxation of tibial shaft
fractures. The device was CE-certiﬁed in August 2005. The
fully resorbable antibiotic coating consists of an amor-
phous poly(D, L-lactide) matrix containing gentamicin
sulphate. The coating is applied through a proprietary
process in which the entire surface of the nail is coated
homogeneously [18]. The total amount of antibiotic con-
tained on one implant ranges from around 10 to 50 mg,
depending on the size of the implant. After implantation,
the gentamicin sulphate is delivered to the surrounding
tissue in a burst release proﬁle starting at the moment of
implantation. Based on studies of release kinetics of the
UTN PROtect
 implant (diameter 8 mm, length 330 mm)
in deionised water, over 40% of the antibiotic is released
within 1 h, 70% within 24 h and 80% within 48 h after
implantation.
Study design
This investigation was a single-arm clinical study of UTN
PROtect
 for operative stabilization of diaphyseal fractures
of the tibial shaft. All patients were enrolled and treated by
different surgeons within one center, Universita ¨tsklinikum
Mu ¨nster, Mu ¨nster, Germany. The treating surgeon was free
to use the implant in various indications. This study started
with deﬁnite treatment of the fractured tibia using the
1420 Arch Orthop Trauma Surg (2011) 131:1419–1425
123antibiotic-coated intramedullary nail. The surgical proce-
dure was performed in accordance with standard practices
and with the manufacturer’s instructions for use of the
UTN PROtect
. Follow-up visits were performed at
5 weeks, 3 and 6 months post-operatively.
Inclusion and exclusion criteria
Patients were included in the study if they met the following
criteria: adult patients of age 18 years or more, having open
or closed tibial shaft fractures amendable for intramedullary
nailing, having failed previous therapies following tibial
fractures and provided signed informed consent. Patients
were excluded if they were pregnant, breast-feeding or
planning to become pregnant during the study, or if they had
consumptiveormalignantprimarydisease,alifeexpectancy
of\3 months, a known allergy to aminoglycosides, or a
conditionthatmadeitimpossibletoobtaininformedconsent
(i.e. a physical or mental incapacity, a history of drug and
alcohol abuse, were unlikely to cooperate, or were declared
legally incompetent).
Antibiotic treatment
The surgeon was free to continue with the standard anti-
biotic regimen to treat fracture pattern, soft tissue damage
and associated injuries. Reasons and duration for post-
operative antibiotic therapy were documented throughout
the follow-up period.
Data collection
The time from the accident to nail implantation was reg-
istered, as well as the patient’s history of previous proce-
dures and infections. Patient data were recorded at the time
of the accident and during the hospital stay. Data on
infections and other adverse events were collected
throughout the follow-up period. Laboratory parameters
analysed were C-reactive protein, leukocyte count, hae-
moglobin and serum gentamicin.
SF-36 scores
The SF-36 physical and mental scores were measured at
6 months post-operatively. The scores are derived from the
SF-36 measure of general health (quality of life) status.
A SF-36 physical score of 50 ± 10 (mean ± standard
deviation) is considered normal [21].
Radiographic assessments
Conventional radiographs of the fractured limb in two
planes with the adjacent knee joint, as well as radiographs
of the ankle were performed for all patients. As per pro-
tocol, radiographs were obtained at time intervals that
reﬂected standard practice: before surgery, intra-opera-
tively, and post-operatively at 5 weeks (±1 week),
3 months (±2 weeks) and 6 months (±2 weeks) after
surgery. Patients were not exposed to additional radiation
solely for study purposes.
Evidence of bone union was determined by radiographic
assessment of four cortices per patient. Consolidated
fracture healing was deﬁned as the bridging of at least three
of four cortices without weight bearing in the anterior-
posterior (AP) and lateral view of the standard radiograph
of the tibia, as previously described [11]. The radiographs
were evaluated by three independent and blinded
radiologists.
Results
Patient characteristics
A total of 21 patients (13 men; 8 women) underwent sur-
gical treatment with UTN PROtect
 from August 2005 to
December 2007 (see Table 1). The mean age of the
patients was 47.7 years (range 18–82 years). The mean
body weight was 76.4 kg (range 40–120 kg) and mean
height was 1.74 m (range 1.55–1.90 m). Three patients had
a history of smoking and one patient had a history of
diabetes.
Of the 21 patients, 19 completed 6 months of follow-up;
one patient was lost to follow-up and another underwent
amputation of the limb for reasons not related to infection.
Nine patients had tibial fractures only and ten patients had
multiple traumas with an injury severity score[16. On the
basis of the AO classiﬁcation, seven fractures were
Table 1 Patient characteristics
Characteristic Number
Age (years)
Mean 47.7
Min–max 18–82
Sex
Male 13
Female 8
Body weight (kg)
Mean 76.4
Min–max 40–120
Height (m)
Mean 1.74
Min–max 1.55–1.90
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123classiﬁed as closed fractures and 12 as open fractures. Of
the open fractures deﬁned according to the classiﬁcation
system of Gustilo and Anderson [8], three fractures were
I, two were II and seven were III of which three were
grade IIIC. Based on the ASA classiﬁcation, ﬁve patients
were rated as ASA I, 11 were rated as ASA II, two as ASA
III and one as ASA IV.
Treatment data
Five patients received immediate intramedullary nailing
within 24 h after sustaining the trauma. Due to additional
injuries, six patients received external ﬁxation initially and
converted to intramedullary nailing within 4 weeks of the
injury. Eight patients received intramedullary nailing
between 4 weeks and 2 years after the initial fracture.
The mean operation time was 164.5 min (range
80–260 min). With respect to the characteristics of the
nails implanted, 4 nails were 8 mm in diameter, 13 nails
were 9 mm and 2 nails were 10 mm. The most frequently
used length was 345 mm (7 nails). During the operation,
the tibia was reamed in 16 patients.
All patients received perioperative antibiotic treatment
with cefuroxim. One patient received clindamicin due to a
history of allergy. Ten patients received antibiotic treat-
ment after surgery for an average of 9.4 days (range
3–30 days). Seven patients presented with severe soft tis-
sue injuries and required soft tissue stabilization with
additional surgery (e.g. vacuum therapy, skin grafting and
secondary skin closure).
Clinical outcomes
No deep wound infections were reported among the
19 patients after 6 months of follow-up. Three patients
reported adverse events, which required hospitalization and
therefore were classiﬁed as serious adverse events. One
patient experienced a thromboembolic event and underwent
angioplasty. Another patient was hospitalized due to pain in
the left hip, which caused impairment of function and
mobility. The third patient suffered local wound healing
problems and required a second operation for debridement.
Additionally, three patients required dynamization. All
patients recovered from the events without complications.
SF-36 scores were measured for 15 patients at the
6-month follow-up visit. The mean SF-36 physical score
was 42.55 (range 19.35–56.68) and the mean SF-36 mental
score was 50.45 (range 27.48–64.98).
Laboratory parameters
Mean C-reactive protein levels remained below normal
range (\5 mg/L) throughout the study, irrespective of
whether patients had open or closed fractures. Patients with
open fractures (n = 12) had a higher mean C-reactive
protein level (4.8 mg/L) than patients with closed fractures
(3.0 mg/L) at 4–7 days post-operatively (Table 2). For all
patients, mean C-reactive protein levels peaked to 4.4 mg/L
at 4–7 days after surgery but thereafter returned to low
levels of \1.5 mg/L (Table 2). Leukocyte and haemoglo-
bin values did not differ markedly from baseline to
6 months after surgery (Table 2). Serum gentamicin levels
were \0.3 lg/ml in all patients at all follow-up assess-
ments after implantation of the UTN PROtect
 gentami-
cin-coated intramedullary nail.
Radiographic outcomes
Fracture healing was deﬁned as the number of cortices that
had bridged as observed in radiographs obtained at
5 weeks, 3 months and 6 months after surgery. Fractures
were considered as healed when three or four cortices had
bridged or partially healed when one or two cortices had
bridged. The number of fully or partially healed fractures
increased steadily over time (Fig. 1). In total, the number
of bridged cortices were 26/76 at 5 weeks, 41/76 at
3 months and 53/76 at 6 months post-operatively.
At 5 weeks after surgery, most patients (89%) showed
partially healed fractures (11 patients with 1/4 and 6
patients with 2/4 bridged cortices). One patient had a
healed fracture (3/4) and one patient had no signs of
healing (0/4). At 3 months post-operatively, nine patients
Table 2 Laboratory values at baseline and up to 6 months follow-up
Baseline Follow-up
4–7 Days 5 Weeks 3 Months 6 Months
C-reactive protein (mg/L)
All patients
Mean 3.1 4.4 1.2 0.8 1.2
Min–max 0.5–12.7 0.5–16.1 0.5–6.8 0.1–4.1 0.2–11.5
Open fractures
Mean 3.0 4.8 1.4 0.9 1.4
Min–max 0.5–12.7 0.5–16.1 0.5–6.8 0.1–4.1 0.2–11.5
Closed fractures
Mean 3.7 3.0 0.9 0.6 0.5
Min–max 0.7–8.5 1.7–4.8 0.5–2.0 0.5–0.8 0.5–0.6
Leukocyte count (910
9/L)
Mean 9.8 7.8 7.1 7.1 6.4
Min–max 4.9–18.6 2.8–14.1 3.6–10.4 0.5–10.4 3.4–8.9
Haemoglobin (g/dL)
Mean 12.6 11.8 13.0 14.0 14.0
Min–max 9.1–16.4 7.3–16.4 9.5–15.7 10.1–16.5 9.9–17.0
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123(47%) had healed fractures (6 patients with 3/4 and
3 patients with 4/4 bridged cortices). The other ten patients
(53%) exhibited healing in progress (1 patient with 2/4 and
9 patients with 1/4 bridged cortices). At 6 months post-
operatively, 11 patients (58%) showed healed fractures
(5 patients with 3/4 and 6 patients with 4/4 bridged corti-
ces), and 8 patients (42%) had partially healed fractures
(6 patients with 2/4 and 2 patients with 1/4 bridged corti-
ces). No non-unions were observed at 3 and 6 months after
surgery.
Weight-bearing capacity
The weight-bearing capacity of the operated leg increased
over time (Fig. 2). At 5 weeks, only 5 patients (26%) could
bear full weight, 12 patients (63%) could bear partial
weight of 15 or 30 kg and 2 patients could not bear any
weight. At 3 months, 12 patients (63%) could bear full
weight and 7 patients (37%) could bear partial weight. At
6 months, the majority of patients (68%) could bear full
weight and the remaining 6 patients (32%) could bear
partial weight.
Discussion
In this study, the use of UTN PROtect
 gentamicin-coated
intramedullary nail in the surgical treatment of open and
closed fractures of the tibial shaft resulted in good clinical,
laboratory and radiological outcomes within 6 months after
surgery. The study population included patients with
complex tibial fractures, severe soft tissue damage, or
multiple traumas, as well as late revision cases. The use of
UTN PROtect
 did not affect or change the indicated
surgical procedure. No deep wound infections were
observed in our patients who showed greater complexity
than those evaluated in previous studies of intramedullary
tibial nailing [5, 9, 14]. One patient had superﬁcial wound
healing problems and was treated with surgical debride-
ment. There were no additional implant-related adverse
events. Two additional patients required dynamization. All
patients recovered well from these events without com-
plications. Fracture union progressed steadily over time
post-operatively. At the follow-up visit at 6 months, 58%
of patients showed healed fractures (three or four bridged
cortices) while the remaining 42% showed partially healed
fractures (one or two bridged cortices). There were no non-
unions among the 19 patients who completed the 6 months
of follow-up.
Infections are an infrequent but important complication
of surgical treatment of long bone fractures, particularly in
the tibia. Estimated rates of infection depend on the type
and severity of fracture and the extent of soft tissue dam-
age. Moreover, bone infections associated with mechanical
devices such as implants are especially difﬁcult to treat. In
serious cases, the only effective treatment involves removal
of the implant, multiple revisions with surgical debride-
ment and intensive antibiotic therapy. Systemic antibiotics
are accepted as standard prophylactic treatment. However,
there are several limitations of systemically delivered
antibiotics. Damage to vascularisation and impaired dif-
fusion into the lumen due to reaming and intramedullary
nailing may prevent systemic antibiotics from reaching the
bone and surrounding tissue in concentrations high enough
for an effective bactericidal action [17]. Other limitations
include systemic toxicity and poor penetration into ische-
mic or necrotic tissues.
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Fig. 1 Fracture healing at 5 weeks, 3 months and 6 months after
surigcal implantation of the UTN PROtect
 gentamicin-coated
intramedullary nail. Four cortices per patient were assessed radio-
logically and the number of cortices (0–4) that had bridged were
determined by three independent and blinded radiologists. The
numbers in the bars indicate the number of patients with 0, 1, 2, 3
or 4 bridged cortices at each follow-up visit
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Fig. 2 Weight-bearing capacity at 5 weeks, 3 and 6 months after
surgical implantation of the UTN PROtect
 gentamicin-coated
intramedullary nail. The numbers in the bars indicate the number
of patients who could bear no weight, 15, 30 kg, or full weight at each
follow-up visit
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123In recent literature a few studies are available, which
give hints that solid nails are more resistant against infec-
tion compared with cannulated nails [10]. These studies are
based only on animal experiences, but there exist no
information about the differences of solid and cannulated
nails in clinical use. Additionally, modern nailing systems
are more or less completely cannulated systems. Occur-
rence of infection depends more on fracture morphology
and soft tissue damage than to nail design.
The main goal of locally delivered antibiotics is to
prevent bacterial colonization of the implant surface,
thereby reducing the risk of implant-related infections.
Another beneﬁt of local delivery systems is that high
concentrations of the antibiotic are achieved in the desired
area without high systemic doses and associated side
effects. In this study, very low serum gentamicin levels of
less than 0.3 lg/ml were detected within 6 months after
implantation of the UTN PROtect
.
PLA coatings, originally designed to enhance osseointe-
grationofimplants,haveshowneffectivenessasamatrixfor
controlled release of bioactive substances [12, 13, 18] Gen-
tamicin-loaded PLA coating of orthopaedic implants offers
severaladvantagesoverotherlocaldeliverysystems.Coated
implantsreleasetheantibioticdirectlyattheimplantsurface,
thereby avoiding the need for additional delivery devices
such as coated collagen sponges. Moreover, PLA matrices
are resorbable unlike PMMA beads and show a more sus-
tained release of antibiotics compared with collagen spon-
ges. Therefore, PLA coatings combine the advantages of the
sustained release of PMMA beads and the biodegradability
ofcollagensponges.Inourstudy,analysisofexplantednails
indicated that gentamicin was completely resorbed within
the 6-month follow-up period (data not shown). This mini-
mizes the risk of generating resistant bacterial strains asso-
ciated with long-term exposure to antibiotics. Nonetheless,
there are no data from comparative studies on the effec-
tivenessofdifferentlocalprophylactic antibioticsystems,in
particular those loaded with gentamicin.
In a pilot study of 8 patients with open tibial fractures
who were treated with intramedullary nailing using the
UTN PROtect
, no infections were observed after 1 year
and all fractures consolidated within 6 months [17]. The
present study provides further evidence of the lack of
deep wound infections after intramedullary ﬁxation of
closed and open tibial fractures with the UTN PROtect

gentamicin-coated tibia nail. Consistent with the reduc-
tion in the risk of infection, local delivery of gentamicin
was associated with good control of inﬂammation during
the initial phase after surgery. Although C-reactive pro-
tein, an inﬂammatory marker, showed a slight peak
within 7 days after surgery, mean levels remained within
normal range (\5 mg/L) throughout the study and
decreased to low levels after 6 months for all patients. In
addition, leukocyte counts and haemoglobin levels
remained constant during the study period.
Bone infections negatively affect fracture healing,
limb function and quality of life. In the present study,
there were no deep wound infections and only one
superﬁcial wound healing problem among 19 patients
within 6 months. This low rate of infection was associ-
ated with good fracture healing over time. The percent-
age of bridged cortices increased from 34% (26/76) at
5 weeks to 70% (53/76) at 6 months after surgery. At
the ﬁnal follow-up visit, all patients showed fully or
partially healed fractures. Full weight-bearing capacity
was achieved in 13 patients (68%) and partial weight
bearing in 6 patients after 6 months. The mean SF-36
physical score at 6 months after surgery in patients who
recovered from tibia fracture is 39.1 [1]. This is slightly
less than the outcome in this study (42.6). However, the
patient number is too small for statistical analysis; it is
just possible to show tendencies. Due to the small
number of patients the authors of this study do not dare
to conclude that antibiotic-coated IM nails prevent
osteomyelitis in severe tibia fractures; nevertheless, no
serious adverse events were seen in this study group.
Local administration of continuously released antibiotics
at the fracture site may be an additional tool to manage
difﬁculties to treat tibia fractures.
Conclusion
Implant-related infections pose an important challenge in
the surgical treatment of tibial shaft fractures. Local
administration of antibiotics, such as through antibiotic
coating of implants, might minimize the risk of infections
and improve clinical and radiological outcomes. In this
prospective, non-randomized case series, we showed that
use of UTN PROtect
 gentamicin-coated intramedullary
nail to treat closed and open tibial fractures was associated
with an absence of deep wound infections, good fracture
healing and increasing weight-bearing capacity after
6 months. These good outcomes were observed even in our
series of patients with complex tibial fractures and multiple
traumas. Given these promising data, further studies are
warranted to establish the use of UTN PROtect
 genta-
micin-coated devices for the prevention of post-surgical
infection in trauma patients and in revision cases.
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